💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for BEG

No earnings history available for this symbol.

📰 Related News & Research

• Cambridge Acquisition Corp. Announces Separate Trading of Class A Ordinary Shares and Warrants Beginning March 30, 2026
  March 28, 2026
  

  Cambridge Acquisition Corp. Announces Separate Trading of Sh...

• Tonix Pharmaceuticals Begins Phase 1 Study of Intranasal Oxytocin (TNX-1900) for Migraine and Craniofacial Pain Treatment
  March 26, 2026
  

  Tonix Pharmaceuticals Announces First Participant Dosed in P...

• Shanghai Henlius Biotech Begins Phase 1b/2 Clinical Trial of HLX701 SIRPα-Fc Fusion Protein for Advanced Colorectal Cancer in Mainland China 12
  March 26, 2026
  

  Shanghai Henlius Biotech, Inc. Announces First Dosing in HLX...

• Natural Alternatives International CEO Mark LeDoux’s Salary to Decrease as He Begins Managing Director Role at European Subsidiary in 2026
  March 21, 2026
  

  Natural Alternatives International, Inc. Announces Major Exe...

• BlockchAIn Digital Infrastructure and Signing Day Sports Complete Merger, Begin Trading as “AIB” on NYSE American
  March 19, 2026
  

  Signing Day Sports and BlockchAIn Digital Infrastructure Com...

• SUMA Acquisition Corporation Prices $150 Million IPO and Begins Trading on NASDAQ
  March 14, 2026
  

  SUMA Acquisition Corporation Announces Pricing of \$150 Mill...

• Oragenics Receives Australian HREC Approval to Begin Phase IIa Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury
  March 12, 2026
  

  Oragenics Receives HREC Approval for Phase IIa Clinical Tria...

• Archimedes Tech SPAC Partners III Co. Announces Separate Trading of Shares and Warrants Beginning March 16, 2026 1
  March 10, 2026
  

  Archimedes Tech SPAC Partners III Co. Announces Commencement...

• Abbisko Therapeutics Begins Phase I/II Clinical Trial of Oral KRAS G12D Inhibitor ABSK141 for Advanced Solid Tumors 12
  March 4, 2026
  

  Abbisko Therapeutics Announces First Patient Dosing in KRAS ...

• JD.com’s supply-chain technology arm, Jingdong Industrials, has begun taking investor orders for its Hong Kong initial public offering (IPO), aiming to raise up to HK$3.3 billion (S$549 million).
  December 3, 2025
  

  JD.com’s supply-chain technology arm, Jingdong Industrials, ...

🔍 View more Reports